a Novel Index for Tissue Perfusion in Predicting Outcome in Patients With Septic Shock

Overview

Septic shock is a life-threatening condition with mortality rate of up to -40%. Septic shock is catheterized by altered microcirculation that leads to tissue hypoperfusion and ultimately multi-organ dysfunction. Hence, maintenance of adequate tissue perfusion is the mainstay of resuscitation of patients with septic shock. Serum lactate is still considered the gold standard for evaluation of tissue perfusion. Thus, according to the latest definition, elevated serum lactate, as an indicator of tissue hypo-perfusion, is required for diagnosis of septic shock. However, lactate level change in response to resuscitation is slow even in survivors. Capillary refill time (CRT) is a simple method for assessing peripheral perfusion. Monitoring CRT was found to be a good tool for guiding resuscitation and delayed CRT showed good ability in predicting mortality in patients with septic shock. To the best of our knowledge, there is no previous report assessing the reliability of an index that include both serum lactate and CRT (lactate/CRT index) in predicting mortality in patients with septic shock. We hypothesize that the lactate/CRT index would have good accuracy in predicting mortality in patient with septic shock.

Full Title of Study: “The Reliability of a Novel Index for Tissue Perfusion in Predicting Outcome in Patients With Septic Shock: a Prospective Observational Study.”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: June 2022

Detailed Description

All patients will be monitored with; non-invasive and invasive arterial blood pressure, five-lead electrocardiography (ECG), hourly urinary output, and central venous pressure (CVP). Management of the patients will be done according to the latest surviving sepsis campaign guidelines in 2016. APACHE II score will be calculated on the time of admission using MDCalc ©. Arterial blood gases, including serum lactate (blood gas analysis device GEM premier 300, Instrumentation Laboratory, Bedford, MA, USA), will be obtained at the time of intensive care unit admission, 6 and 12 hours after admission. Capillary refill time will be measured by applying enough pressure to cause skin blanching to the ventral surface of the distal phalanx of right index finger and the pressure will be then maintained for 10 seconds. The time for return of the normal skin color will be registered with a stopwatch. CRT will be recoded at the same time point as the blood sample. The change in serum lactate (∆ Lactate), and CRT (∆ CRT) will be calculated as the difference between each two-consecutive measurement. Lactate/CRT index will be calculated as the product of multiplying the CRT and serum lactate.

Interventions

  • Diagnostic Test: Lactate/CRT index
    • index will be calculated as the product of multiplying the CRT and serum lactate

Clinical Trial Outcome Measures

Primary Measures

  • the ability of Lactate/CRT index in predicting patient’s outcome
    • Time Frame: 6 hour after admission
    • multiplying the CRT and serum lactate

Secondary Measures

  • ability of Lactate/CRT index in predicting patient’s outcome
    • Time Frame: 12 hours after admission
    • multiplying the CRT and serum lactate
  • ability of Lactate in predicting patient’s outcome
    • Time Frame: 6 and 12 hours after admission
    • mg/dl
  • ability of CRT in predicting patient’s outcome
    • Time Frame: 6 and 12 hours after admission
    • Capillary refill time will be measured by applying enough pressure to cause skin blanching to the ventral surface of the distal phalanx of right index finger and the pressure will be then maintained for 10 seconds. The time for return of the normal skin color will be registered with a stopwatch
  • change in serum lactate
    • Time Frame: WITHIN 1 HOUR, 6 and 12 hours after admission
    • the difference between each two-consecutive measurement
  • change in CRT
    • Time Frame: WITHIN 1 HOUR, 6 and 12 hours after admission
    • the difference between each two-consecutive measurement

Participating in This Clinical Trial

Inclusion Criteria

  • Patients with clinically suspected septic shock, older than 18 years old Exclusion Criteria:

  • Patients less than 18 years. – patients with evident blood loss. – patients with metastatic cancer. – Patients with Child B or C liver cirrhosis – patients with estimated glomerulo filtartion rate less than 30 ml/min/m2

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Cairo University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Ahmed Hasanin, Principal Investigator – Cairo University
  • Overall Official(s)
    • ahmed hasanin, Principal Investigator, Cairo University Kasr Alainy Faculty of Medicine
  • Overall Contact(s)
    • Maha Mostafa, 01000365115, maha.mostafa@cu.edu.eg

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.